Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
California Governor Announces $100m Insulin Initiative
State Will Produce Its Own Generic Biosimilar Products
Jul 19 2022
•
By
Chloe Kent
California Gov. Gavin Newsom's decision expands availability of CalRx brand OTC naloxone to all consumers who could potentially need the emergency treatment used in opioid overdose reversal. • Source: Shutterstock
More from Policy & Regulation
More from Generics Bulletin